Luyan Pharma Co Ltd
SZSE:002788

Watchlist Manager
Luyan Pharma Co Ltd Logo
Luyan Pharma Co Ltd
SZSE:002788
Watchlist
Price: 17.04 CNY 2.04% Market Closed
Market Cap: ¥6.6B

Wall Street
Price Targets

Price Targets Summary
Luyan Pharma Co Ltd

There are no price targets for Luyan Pharma Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Luyan Pharma Co Ltd Competitors:
Price Targets

Revenue
Forecast

13% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
13% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

For the last 11 years the compound annual growth rate for Luyan Pharma Co Ltd's revenue is 13%. The projected CAGR for the next 1 year is 24%.

Operating Income
Forecast

12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
12% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Operating Income forecast
is not available for
Luyan Pharma Co Ltd

Net Income
Forecast

11% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
11% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

For the last 11 years the compound annual growth rate for Luyan Pharma Co Ltd's net income is 11%. The projected CAGR for the next 1 year is 33%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Luyan Pharma Co Ltd's stock price target?
Not Available

Luyan Pharma Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Luyan Pharma Co Ltd's Revenue forecast?
Projected CAGR
24%

For the last 11 years the compound annual growth rate for Luyan Pharma Co Ltd's revenue is 13%. The projected CAGR for the next 1 year is 24%.

What is Luyan Pharma Co Ltd's Net Income forecast?
Projected CAGR
33%

For the last 11 years the compound annual growth rate for Luyan Pharma Co Ltd's net income is 11%. The projected CAGR for the next 1 year is 33%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett